BCAT1 overexpression has been shown to be associated with several cancers including glioblastoma [17], nasopharyngeal carcinoma [18], ovarian cancer [19] and hepatocellular carcinoma [20]. This evidence concerns the gene BCAT1 and ovarian carcinoma.